CD4 and neoplasm: Immunofluorescence assays (Fig. 6R, S) showed that tumor tissues from mice treated with sh-LINC01123 + miR-214-3p-inhibitor exhibited decreased positive rates of CD4 and CD8 proteins (P < 0.05).